6 Pat., WO 2008/117037, 2008.
7 Pat., WO 2008/117060, 2008.
8 G. R. Desiraju, Angew. Chem., Int. Ed., 2007, 46, 8342–8356, DOI:
10.1002/anie.200700534.
9 G. R. Desiraju, Angew. Chem., Int. Ed. Engl., 1995, 34, 2311–2327,
DOI: 10.1002/anie.199523111.
10 E. Nauha, H. Saxell, M. Nissinen, E. Kolehmainen, A. Schafer and
R. Schlecker, CrystEngComm, 2009, 11, 2536–2547, DOI: 10.1039/
b905511h.
11 E. Nauha, A. Ojala, M. Nissinen and H. Saxell, CrystEngComm,
2011, 13, 4956–4964, DOI: 10.1039/c1ce05077j.
12 I. D. H. Oswald, W. D. S. Motherwell and S. Parsonsa, Acta
Crystallogr., Sect. B: Struct. Sci., 2005, 61, 46–57, DOI: 10.1107/
S0108768104028605.
13 H. W. Roesky and M. Andruh, Coord. Chem. Rev., 2003, 236, 91–119,
DOI: 10.1016/S0010-8545(02)00218-7.
14 I. D. H. Oswald, D. R. Allan, P. A. McGregor, W. D. S. Motherwell,
S. Parsons and C. R. Pulham, Acta Crystallogr., Sect. B: Struct. Sci.,
2002, 58, 1057–1066, DOI: 10.1107/S0108768102015987.
15 A. Ranganathan, V. R. Pedireddi, G. Sanjayan, K. N. Ganesh and
C. N. R. Rao, J. Mol. Struct., 2000, 522, 87–94, DOI: 10.1016/
S0022-2860(99)00356-7.
16 S. Varughese and V. R. Pedireddi, Chem.–Eur. J., 2006, 12, 1597–
1609, DOI: 10.1002/chem.200500570.
17 T.-F. Tan, J. Han, M.-L. Pang, H.-B. Song, Y.-X. Ma and
J.-B. Meng, Cryst. Growth Des., 2006, 6, 1186–1193, DOI: 10.1021/
cg060009y.
structures in a subtle manner. The main hydrogen bond pairing
was always the same, but the size of the molecule influenced the
usage of the rest of the donors and acceptors. In the TM co-
crystals with 4,40-bipyridine and 1,2-bis(4-pyridyl)ethane one N–
H donor and all or most of the C]S acceptors are unused, while
in the TE co-crystal with 4,40-bipyridine only a pyridine acceptor
is unused and in the TE co-crystal with 1,2-bis(4-pyridyl)ethane
all donors and acceptors are in use. This is because the larger
molecules have more conformational freedom and can pack well
even with more hydrogen bonds in use. For the 2,20-bipyridine
co-crystals the difference is not clear while TE makes a channel
structure known to also fit other molecules and TM builds
a clathrate type structure templated by the 2,20-bipyridine.
The stoichiometric diversity in the co-crystals with the same
bipyridines raises the question of whether there could be more
co-crystals with different molar ratios like in the work of Trask
et al.28 on caffeine co-crystals. The TE–4,40-bipyridine sample
grinded with EtOH could be an example of this, but further
investigation is required. We believe there are also numerous
other possibilities for co-crystals as well as solvates of TM and
TE. Similar molecules with flexible chains attached ortho on
a benzene ring could also be reliable co-crystal formers and we
plan on further investigating these.
€
18 B. Ye, M. Tong and X. Chen, Coord. Chem. Rev., 2005, 249, 545–565,
DOI: 10.1016/j.ccr.2004.07.006.
19 PANalytical B.V., 2006, 2.2b.
20 G. M. Sheldrick, Acta Crystallogr., Sect. A: Found. Crystallogr., 2008,
64, 112–122, DOI: 10.1107/S0108767307043930.
Acknowledgements
21 Z. Otwinowski, D. Borek, W. Majewski and W. Minor, Acta
Crystallogr., Sect. A: Found. Crystallogr., 2003, 59, 228–234, DOI:
10.1107/S0108767303005488.
22 C. F. Macrae, P. R. Edgington, P. McCabe, E. Pidcock, G. P. Shields,
R. Taylor, M. Towler and J. van de Streek, J. Appl. Crystallogr., 2006,
39, 453–457, DOI: 10.1107/S002188980600731X.
We would like to thank the academy of Finland (proj. no.
116503) for partly funding the work and Dr Heidi Saxell at
BASF SE in Ludwigshafen, Germany for fruitful discussions.
23 R. K. Harris, Analyst, 2006, 131, 351–373, DOI: 10.1039/b516057j.
24 M. C. Etter and J. C. MacDonald, Acta Crystallogr., Sect. B:
Struct. Sci., 1990, B46, 256–262; J. Bernstein, R. E. Davis,
L. Shimoni and N.-L. Chung, Angew. Chem., Int. Ed. Engl., 1995,
34, 1555–1573.
Notes and references
1 A. D. Bond, CrystEngComm, 2007, 9, 833–834, DOI: 10.1039/
b708112j.
€
2 C. B. Aakeroy and D. J. Salmon, CrystEngComm, 2005, 7, 439–448,
DOI: 10.1039/b505883j.
ꢂ
ꢂ
25 A. I. Kitaıgorodskiı, Organic Chemical Crystallography, Consultants
Bureau, New York, 1961.
3 O. Almarsson and M. J. Zaworotko, Chem. Commun., 2004, (17),
1889–1896, DOI: 10.1039/b402150a.
26 Calculation
of
Molecular
Properties
and
Drug-likeness,
4 N. Blagden, M. de Matas, P. T. Gavan and P. York, Adv. Drug
Delivery Rev., 2007, 59, 617–630, DOI: 10.1016/j.addr.2007.05.011.
5 D. McNamara, S. Childs, J. Giordano, A. Iarriccio, J. Cassidy,
M. Shet, R. Mannion, E. O’Donnell and A. Park, Pharm. Res.,
2006, 23, 1888–1897, DOI: 10.1007/s11095-006-9032-3.
27 B. Piotrkowska, A. Wasilewska, M. Gdaniec and T. Polonski,
CrystEngComm, 2008, 10, 1421–1428, DOI: 10.1039/b806061d.
28 A. V. Trask, J. van de Streek, W. D. S. Motherwell and W. Jones,
Cryst. Growth Des., 2005, 5, 2233–2241, DOI: 10.1021/cg0501682.
This journal is ª The Royal Society of Chemistry 2011
CrystEngComm, 2011, 13, 6531–6537 | 6537